Home » Stocks » Progenity

Progenity, Inc. (PROG)

Stock Price: $8.96 USD -0.14 (-1.54%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 404.67M
Revenue (ttm) 113.31M
Net Income (ttm) n/a
Shares Out 45.16M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $8.96
Previous Close $9.10
Change ($) -0.14
Change (%) -1.54%
Day's Open 9.07
Day's Range 8.80 - 9.07
Day's Volume 41,886
52-Week Range 7.63 - 15.92

More Stats

Market Cap 404.67M
Enterprise Value 465.67M
Earnings Date (est) Aug 13, 2020
Ex-Dividend Date n/a
Shares Outstanding 45.16M
Float 947,073
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 485,325
Short Ratio 1.23
Short % of Float 3.72%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 3.57
PB Ratio n/a
Revenue 113.31M
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash -61.00M
Net Cash / Share -1.35
Gross Margin 38.39%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 2
Overweight 2
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(53.46% upside)
Current: $8.96
Target: 13.75
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth12.51%-
Gross Profit43.4935.90
Operating Income-140-114
Net Income-148-129
Shares Outstanding4.884.66
Earnings Per Share-46.87-27.72
Operating Cash Flow-106-65.13
Capital Expenditures-3.73-4.83
Free Cash Flow-110-69.96
Cash & Equivalents33.0469.21
Total Debt73.3772.74
Net Cash / Debt-40.33-3.53
Book Value-83.87-36.97
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Progenity, Inc.
Country United States
Employees 676
CEO Harry Stylli

Stock Information

Ticker Symbol PROG
Stock Exchange NASDAQ
Unique Identifier NASDAQ: PROG
IPO Date June 19, 2020


Progenity, Inc., a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. It offers testing services for common hereditary disorders, cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and Jewish genetic diseases; pan-ethnic carrier screening services; non-invasive prenatal, miscarriage, and pharmacogenetic testing services; and ovarian assessment reports for women. The company also provides pediatric testing services. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November, 2013. The company was incorporated in 2012 and is based in San Diego, California with a laboratory in Ann Arbor, Michigan. It has a bill payment location in Detroit, Michigan.